Baker Bros. Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-171,026
| Closed | -$1.86M | – | 96 |
|
|
2024
Q2 | $1.86M | Sell |
171,026
-236,191
| -58% | -$2.57M | 0.02% | 82 |
|
|
2024
Q1 | $7.63M | Buy |
+407,217
| New | +$7.63M | 0.1% | 56 |
|
|
2018
Q4 | – | Sell |
-567,497
| Closed | -$80.2M | – | 96 |
|
|
2018
Q3 | $80.2M | Sell |
567,497
-45,803
| -7% | -$6.47M | 0.53% | 18 |
|
|
2018
Q2 | $96M | Sell |
613,300
-33,528
| -5% | -$5.25M | 0.72% | 14 |
|
|
2018
Q1 | $104M | Buy |
646,828
+30,314
| +5% | +$4.88M | 0.88% | 14 |
|
|
2017
Q4 | $102M | Buy |
616,514
+211,029
| +52% | +$34.8M | 0.88% | 12 |
|
|
2017
Q3 | $25.3M | Buy |
405,485
+197,157
| +95% | +$12.3M | 0.2% | 33 |
|
|
2017
Q2 | $16.6M | Hold |
208,328
| – | – | 0.15% | 37 |
|
|
2017
Q1 | $14.8M | Hold |
208,328
| – | – | 0.12% | 38 |
|
|
2016
Q4 | $10.6M | Hold |
208,328
| – | – | 0.1% | 48 |
|
|
2016
Q3 | $9.59M | Sell |
208,328
-15,720
| -7% | -$724K | 0.09% | 57 |
|
|
2016
Q2 | $6.75M | Hold |
224,048
| – | – | 0.07% | 64 |
|
|
2016
Q1 | $7.18M | Buy |
224,048
+119,048
| +113% | +$3.82M | 0.08% | 65 |
|
|
2015
Q4 | $6.12M | Hold |
105,000
| – | – | 0.05% | 72 |
|
|
2015
Q3 | $4.44M | Hold |
105,000
| – | – | 0.04% | 79 |
|
|
2015
Q2 | $7.67M | Buy |
105,000
+30,000
| +40% | +$2.19M | 0.07% | 68 |
|
|
2015
Q1 | $3.77M | Hold |
75,000
| – | – | 0.03% | 83 |
|
|
2014
Q4 | $2.75M | Hold |
75,000
| – | – | 0.03% | 91 |
|
|
2014
Q3 | $2.36M | Buy |
+75,000
| New | +$2.36M | 0.03% | 84 |
|